Synthesis of poison-frog alkaloids 233A, 235U, and 251AA and their inhibitory effects on neuronal nicotinic acetylcholine receptors

Naoki Toyooka*, Soushi Kobayashi, Dejun Zhou, Hiroshi Tsuneki, Tsutomu Wada, Hideki Sakai, Hideo Nemoto, Toshiyasu Sasaoka, H. Martin Garraffo, Thomas F. Spande, John W. Daly

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

We previously reported that the synthetic quinolizidine 1-epi-207I is a relatively selective blocker of α7 nicotinic acetylcholine receptors. We now synthesized the analogous poison frog alkaloids 233A, 235U, and 251AA, and investigated the biological activities at two major types of neuronal nicotinic receptors. Electrophysiological study showed that the alkaloid 233A blocked α7 and α4β2 currents with similar potencies. Alkaloids 235U and 251AA also showed similar potencies for blockade of α7 and α4β2 currents. Thus, based on these studies, it would appear that C4 substituents greater in length than the allyl of 1-epi-207I reduce α7-potency without affecting α4β2-potency.

Original languageEnglish
Pages (from-to)5872-5875
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number21
DOIs
StatePublished - 2007/11/01

Keywords

  • 1-epi-207I
  • 233A
  • 235U
  • 251AA
  • Neuronal nicotinic acetylcholine receptors
  • Poison-frog alkaloids

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis of poison-frog alkaloids 233A, 235U, and 251AA and their inhibitory effects on neuronal nicotinic acetylcholine receptors'. Together they form a unique fingerprint.

Cite this